Oncogenic TrkA fusion products [50] potentiate NGF-dependent carcinogenesis in CRC, thyroid cancer, and AML, leading to the concept of NTRK1 functioning as an oncogene [39]. The gene discussed is NTRK1; the disease is thyroid cancer.